Naveen Suryadevara, Ph.D.

Naveen
Suryadevara
Ph.D.
Associate Basic Scientist
naveenchandra.suryadevara@vumc.org

Dr. Suryadevara received his M.Sc. in Biochemistry from Andhra University in 2007, and doctorate in Biotechnology in 2015 from Jawaharlal Nehru Technological University Hyderabad, India. His dissertation was focused on identifying susceptible SNP’s in Toll like receptors (TLR’s) and correlation of cytokines in Mycobacterium Lepra infection which resulted in 5 primary research publications. After graduation he worked as a Sr. Technical officer at Center for DNA Fingerprinting and Diagnostics (CDFD, Hyderabad, India). In 2015 Dr. Suryadevara joined Dr. Joyce’s laboratory at Vanderbilt University Medical Center as a postdoctoral trainee. His research was focused on lung-resident memory CD8+ T cells, developed recombinant proteins to install antigen specific CD8+ T cell memory in lungs and mechanisms of MHC class II antigen presentation. During this tenure he contributed to a review and a publication. He was awarded AAI Trainee Abstract Award in 2019 and best Poster Award, North American Comparative Immunology Workshop in 2017. Dr. Suryadevara is now occupying senior staff scientist position in the laboratory of Dr. James E. Crowe, Jr. and is involved in developing methods pertaining to rapid identification of therapeutic antibodies against viral infections.

SuryadevaraNaveenPhD

Ginger DeBellis

Ginger
DeBellis
Lead Project Manager
ginger.e.debellis@vumc.org

Ginger DeBellis is a Project Manager for the Vanderbilt Vaccine Center. She received her B.S. in Biology from Hawaii Pacific University. Ginger spent several years working on Next Generation Sequencing research projects at the Genomic Core Facility at Pennsylvania State University.

Luke Myers

Luke
Michael
Myers
Senior Application Developer
michael.l.myers@vumc.org

Luke Myers is a data analyst in the VVC. Luke has a Bachelor’s in Philosophy from the University of Oregon and transitioned into IT work with a focus on databases and Linux systems soon after graduating in 2010. When he is not thinking about data integrity and analytics, his interests include the science behind photography and how we make meaning.

MyersLukeMichael

Towards a universal flu vaccine

Flu shots can be hard to sell to the public. Even a run-of-the-mill influenza infection can be debilitating to otherwise healthy people, and lethal to those who are elderly or frail, so vaccinations are important. The problem is that flu vaccines deliver inconsistent performance. “In a good season, we’re up to 60% effectiveness, but in bad, mismatched years it can be as low as 10% or 20%,” says Barney Graham, deputy director of the Vaccine Research Center at the US National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland.

Partnership to help bring Zika virus therapy to clinic

Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago. The mosquito-borne Zika virus is believed to cause microcephaly, unusually small heads, and other congenital malformations in children born to infected women. Currently there is no way to prevent Zika virus infection or its aftermath.

Alex Bunnell

Alex
Bunnell
Project Manager
alexander.bunnell@vumc.org

Alexander Bunnell is an Associate Project Manager for the VVC. He is a graduate of Lipscomb University where he studied Project Management and Corporate Management. He provides support for the planning, developing and executing of day to day projects. He manages intellectual property, material requests and CDA requests, in addition to assisting with grant and contract progress reports. He is also an acting liaison between CTTC and the lab and assists the Senior Program Manager with collaboration management.

BunnellAlex

VUMC partners with Batavia to move promising Zika antibody therapy closer to the clinic

Researchers at Vanderbilt University Medical Center (VUMC) are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago. The mosquito-borne Zika virus is believed to cause microcephaly, unusually small heads, and other congenital malformations in children born to infected women. Currently there is no way to prevent Zika virus infection or its aftermath.

Andrew Trivette

Andrew
Trivette
Application Developer
andrew.trivette@vumc.org

Andrew Trivette completed his BS and MS in Biology at Middle Tennessee State University, where his MS research focused on the role of certain membrane-bound proteins in the Saccharomyces cerevisiae secretory pathway. Then he spent 3 years at North Carolina State University where he worked in Bioinformatics, studying how and where translation occurs in Arabidopsis thaliana and attempting to identify novel, non-canonical translation start sites using ribosome footprinting data.  

TrivetteAndrew

Tracy Martin

Tracy
Martin
Sr. Financial Analyst
tracy.martin@vumc.org

Hello, I'm Tracy Martin. I am originally from Nashville, and I have lived many different places over the years, but landed back in Tennessee to settle down just outside of Nashville.  I graduated from Western Governors University with a degree in Business and Human Resources Management, with a strong concentration in Accounting and Finance principles.  I am in my twenty-fifth year with VUMC, having worked in the Children’s Hospital in Pediatric and Adolescent inpatient units, Myelosuppression and Hematology/Oncology units, and Nursing Administration for the first twenty-one years and in Infectious Diseases at the Comprehensive Care Center with the Southeast AIDS Education & Training Center since 2015 on a grant for educating providers who care for people living with HIV.  Outside of work, you would most likely find me reading, working in my yard planting flowers and trees, or exploring new places with my camera.

Laura Powell receives scholarship for the Keystone conference

Laura Powell has been awarded a Keystone Symposia Future of Science Fund scholarship to attend the upcoming meeting on Positive-Strand RNA Viruses, Jun 9 - Jun 13, 2019, in INEC, Killarney Convention Centre in Killarney, Co. Kerry.  Congrats Laura!